List of works by Linda Mellbin

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

scientific article published on 01 January 2020

Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes

scientific article published on 27 March 2015

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

scientific article published on 14 June 2018

Cardiovascular prevention in patients with diabetes and prediabetes

scientific article published on April 2008

Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG

scientific article published on 20 April 2016

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design

scientific article published on 30 April 2020

Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

scientific article published on 22 February 2012

Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort

scientific article published on 11 October 2018

Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.

scientific article

Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

scientific article published in January 2017

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.

scientific article

Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.

scientific article

Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study

scientific article published on 29 April 2016

Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls

scientific article

Diabetes, prediabetes and cardiovascular risk.

scientific article published on May 2010

Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.

scientific article published on June 2017

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial

scientific article published on 2 September 2013

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study

scientific article published in April 2014

Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction

article

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

scientific article

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

scientific article

ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD

scientific article

Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.

scientific article published on January 2008

Effect of dipeptidyl peptidase-4 inhibitors on complement activation

scientific article published on 13 July 2020

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje

scientific article published on 05 October 2018

Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort

scientific article published on 21 December 2016

Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort

scientific article published on 11 July 2018

Evidence for a beneficial effect of glucose-insulin-potassium in patients with acute coronary syndromes: Did the IMMEDIATE trial solve an unanswered question?

scientific article published on 01 September 2012

Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.

scientific article published on 28 March 2012

Glucose monitoring by means of an intravenous microdialysis catheter technique.

scientific article

Glucose perturbations and cardiovascular risk: challenges and opportunities.

scientific article published on July 2012

Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes

article

High awareness of diabetes as a key cardiovascular risk factor among healthcare professionals but suboptimal treatment: Results from a survey of the European Association of Preventive Cardiology

scientific article published on 24 March 2020

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.

scientific article published on 6 April 2018

Implications of abnormal glucose metabolism in patients with coronary artery disease

scientific article

Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity.

scientific article published on 30 July 2015

Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

scientific article published on 13 July 2020

Is glucose normalization an evidence-based treatment for patients with type 2 diabetes mellitus?

scientific article published on 28 October 2008

Joint ESC/EASD guidelines on diabetes, where are we now and where should we go?

scientific article published in November 2012

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

scientific article published on 10 February 2019

New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone

scientific article published in May 2017

Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting.

scientific article published on March 2010

Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial

scientific article published on 31 August 2019

Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population

scientific article published on 04 September 2020

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

scientific article

Percutaneous coronary intervention versus conservative treatment for non ST-segment elevation myocardial infarction in patients above 80 years of age

scientific article published on 24 May 2018

Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome

scientific article published on 23 March 2017

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

scientific article published on 26 February 2011

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.

scientific article published on 24 November 2008

Risk factor reduction in type 2 diabetes demands a multifactorial approach

scientific article published on 01 December 2019

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

scientific article published on 20 February 2020

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin

scientific article published on 16 November 2020

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial

scientific article published on 19 December 2018

The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study

scientific article published on 19 May 2014

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology

scientific article published on 21 June 2017

The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management

scientific article published on 03 September 2014

The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial

scientific article published in April 2017

The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial

scientific article

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

scientific article published on 21 December 2007

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial

scientific article published on 09 November 2012

Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry

Will oral semaglutide be a game-changer in the management of type 2 diabetes in primary care?

scientific article published on 18 August 2020

[Diabetes and myocardial infarction: intensive glucose control important according to international guidelines]

scientific article published on 01 November 2006

[Pay for disease or invest in health?]

scientific article published in September 2012

Paulina is supported by:

About Paulina

Help